Tonukari, 2010 - Google Patents
Theileria parva apical membrane antigen-1 (AMA-1) shares conserved sequences with apicomplexan homologsTonukari, 2010
View PDF- Document ID
- 2881835316114390080
- Author
- Tonukari N
- Publication year
- Publication venue
- Int J Biotech Mol Biol Res
External Links
Snippet
Theileria parva infects and transforms lymphocytes of cattle and African buffalo causing the disease called East Coast fever (ECF). The AMA-1 homolog in T. parva was isolated, cloned and sequenced. The predicted amino acid sequence was further analyzed. The partial gene …
- 101710005679 POLR2A 0 title abstract description 63
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gaur et al. | Parasite ligand–host receptor interactions during invasion of erythrocytes by Plasmodium merozoites | |
Daly et al. | A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice | |
Crewther et al. | Protective immune responses to apical membrane antigen 1 of Plasmodium chabaudi involve recognition of strain-specific epitopes | |
Marshall et al. | A second merozoite surface protein (MSP-4) of Plasmodium falciparum that contains an epidermal growth factor-like domain | |
Bargieri et al. | New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellin | |
Dreyer et al. | Passive immunoprotection of Plasmodium falciparum-infected mice designates the CyRPA as candidate malaria vaccine antigen | |
Fraser et al. | Erythrocyte-binding activity of Plasmodium yoelii apical membrane antigen-1 expressed on the surface of transfected COS-7 cells | |
Valderrama-Aguirre et al. | Antigenicity, immunogenicity, and protective efficacy of Plasmodium vivax MSP1 PV200l: a potential malaria vaccine subunit | |
Black et al. | Apical location of a novel EGF-like domain-containing protein of Plasmodium falciparum | |
Mun et al. | Role of Toxoplasma gondii HSP70 and Toxoplasma gondii HSP30/bag1 in antibody formation and prophylactic immunity in mice experimentally infected with Toxoplasma gondii | |
Black et al. | The Plasmodium vivax homologues of merozoite surface proteins 4 and 5 from Plasmodium falciparum are expressed at different locations in the merozoite | |
Moll et al. | A novel DBL-domain of the P. falciparum 332 molecule possibly involved in erythrocyte adhesion | |
Schussek et al. | Immunization with apical membrane antigen 1 confers sterile infection-blocking immunity against Plasmodium sporozoite challenge in a rodent model | |
Soares et al. | A Plasmodium vivax vaccine candidate displays limited allele polymorphism, which does not restrict recognition by antibodies | |
Moreno-Pérez et al. | The GPI-anchored 6-Cys protein Pv12 is present in detergent-resistant microdomains of Plasmodium vivax blood stage schizonts | |
Blackwell et al. | Functional analysis of Plasmodium falciparum merozoite antigens: implications for erythrocyte invasion and vaccine development | |
Burns Jr et al. | Immunization against Plasmodium chabaudi malaria using combined formulations of apical membrane antigen-1 and merozoite surface protein-1 | |
Ogun et al. | Plasmodium yoelii: effects of red blood cell modification and antibodies on the binding characteristics of the 235-kDa rhoptry protein | |
Hui et al. | Roles of conserved and allelic regions of the major merozoite surface protein (gp195) in immunity against Plasmodium falciparum | |
Newbold et al. | A possible molecular basis for strain specific immunity to malaria | |
Angel et al. | The Plasmodium vivax Pv41 surface protein: identification and characterization | |
Mongui et al. | Characterisation of the Plasmodium vivax Pv38 antigen | |
Mahajan et al. | Genetic polymorphism in Plasmodium falciparum vaccine candidate antigens | |
Tonukari | Theileria parva apical membrane antigen-1 (AMA-1) shares conserved sequences with apicomplexan homologs | |
O'Dea et al. | Processing of the Plasmodium chabaudi chabaudi AS merozoite surface protein 1 in vivo and in vitro |